Sato H - Search Results

1

Model-based meta-analysis of HbA1c reduction across SGLT2 inhibitors using dose adjusted by urinary glucose excretion.

Sato H, Ishikawa A, Yoshioka H, Jin R, Sano Y, Hisaka A. Sato H, et al. Sci Rep. 2024 Oct 21;14(1):24695. doi: 10.1038/s41598-024-76256-6. Sci Rep. 2024. PMID: 39433865 Free PMC article.

2

Model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients.

Yoshioka H, Sato H, Hatakeyama H, Hisaka A. Yoshioka H, et al. Among authors: sato h. Blood Adv. 2018 May 22;2(10):1066-1075. doi: 10.1182/bloodadvances.2017013805. Blood Adv. 2018. PMID: 29760204 Free PMC article.

3

Model-based meta-analysis of changes in circulatory system physiology in patients with chronic heart failure.

Takaoka R, Soejima Y, Guro S, Yoshioka H, Sato H, Suzuki H, Hisaka A. Takaoka R, et al. Among authors: sato h. CPT Pharmacometrics Syst Pharmacol. 2021 Sep;10(9):1081-1091. doi: 10.1002/psp4.12676. Epub 2021 Jul 16. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34218511 Free PMC article.

4

Model-based meta-analysis of ethnic differences and their variabilities in clearance of oral drugs classified by clearance mechanism.

Sato H, Marutani R, Takaoka R, Mori-Fegan D, Wang X, Maeda K, Kusuhara H, Suzuki H, Yoshioka H, Hisaka A. Sato H, et al. CPT Pharmacometrics Syst Pharmacol. 2023 Aug;12(8):1132-1142. doi: 10.1002/psp4.12980. Epub 2023 Jun 12. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37309079 Free PMC article.

5

Data-driven disease progression model of Parkinson's disease and effect of sex and genetic variants.

Jin R, Yoshioka H, Sato H, Hisaka A. Jin R, et al. Among authors: sato h. CPT Pharmacometrics Syst Pharmacol. 2024 Apr;13(4):649-659. doi: 10.1002/psp4.13112. Epub 2024 Feb 19. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38369942 Free PMC article.

6

Global Comparison of Changes in the Number of Test-Positive Cases and Deaths by Coronavirus Infection (COVID-19) in the World.

Hisaka A, Yoshioka H, Hatakeyama H, Sato H, Onouchi Y, Anzai N. Hisaka A, et al. Among authors: sato h. J Clin Med. 2020 Jun 18;9(6):1904. doi: 10.3390/jcm9061904. J Clin Med. 2020. PMID: 32570833 Free PMC article.

7

Scores of Health-Related Quality of Life Questionnaire Worsen Consistently in Patients of COPD: Estimating Disease Progression over 30 Years by SReFT with Individual Data Collected in SUMMIT Trial.

Kawamatsu S, Jin R, Araki S, Yoshioka H, Sato H, Sato Y, Hisaka A. Kawamatsu S, et al. Among authors: sato y, sato h. J Clin Med. 2020 Aug 18;9(8):2676. doi: 10.3390/jcm9082676. J Clin Med. 2020. PMID: 32824840 Free PMC article.

8

Soejima K, Sato H, Hisaka A. Soejima K, et al. Among authors: sato h. Clin Pharmacokinet. 2022 Feb;61(2):295-305. doi: 10.1007/s40262-021-01069-z. Epub 2021 Sep 13. Clin Pharmacokinet. 2022. PMID: 34514537

9

Exercise training outcomes in patients with chronic heart failure with reduced ejection fraction depend on patient background.

Soejima Y, Yoshioka H, Guro S, Sato H, Hatakeyama H, Sato Y, Fujimoto Y, Anzai N, Hisaka A. Soejima Y, et al. Among authors: sato y, sato h. Front Cardiovasc Med. 2024 Jan 31;11:1330235. doi: 10.3389/fcvm.2024.1330235. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38361589 Free PMC article.

10

Determinants of Intestinal Availability for P-glycoprotein Substrate Drugs Estimated by Extensive Simulation With Mathematical Absorption Models.

Ando H, Hatakeyama H, Sato H, Hisaka A, Suzuki H. Ando H, et al. Among authors: sato h. J Pharm Sci. 2017 Sep;106(9):2771-2779. doi: 10.1016/j.xphs.2017.04.065. Epub 2017 May 4. J Pharm Sci. 2017. PMID: 28479352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,055 results

Search Page

Filters